Clinical features of H1N1 2009 infection in critically ill immunocompromised patients

Seasonal influenza virus has been described as an emerging and severe pathogen in immunocompromised hosts. Since the beginning of the 2009 influenza A novel H1N1 pandemic, several series have described the clinical course of the disease in various populations. We report the clinical course of H1N1 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Camous, Laurent, Lemiale, Virginie, Canet, Emmanuel, Max, Adeline, Schnell, David, Le Goff, Jerome, Rabbat, Antoine, Schlemmer, Benoit, Azoulay, Élie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887153/
https://www.ncbi.nlm.nih.gov/pubmed/20392286
http://dx.doi.org/10.1186/cc8927
_version_ 1782182515771965440
author Camous, Laurent
Lemiale, Virginie
Canet, Emmanuel
Max, Adeline
Schnell, David
Le Goff, Jerome
Rabbat, Antoine
Schlemmer, Benoit
Azoulay, Élie
author_facet Camous, Laurent
Lemiale, Virginie
Canet, Emmanuel
Max, Adeline
Schnell, David
Le Goff, Jerome
Rabbat, Antoine
Schlemmer, Benoit
Azoulay, Élie
author_sort Camous, Laurent
collection PubMed
description Seasonal influenza virus has been described as an emerging and severe pathogen in immunocompromised hosts. Since the beginning of the 2009 influenza A novel H1N1 pandemic, several series have described the clinical course of the disease in various populations. We report the clinical course of H1N1 2009 infection in 10 immunocompromised patients. Half of the patients received long-term steroid therapy. Disease was characterized by a clinical picture similar to that of non-immunocompromised patients but with prolonged course and higher mortality.
format Text
id pubmed-2887153
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28871532011-04-14 Clinical features of H1N1 2009 infection in critically ill immunocompromised patients Camous, Laurent Lemiale, Virginie Canet, Emmanuel Max, Adeline Schnell, David Le Goff, Jerome Rabbat, Antoine Schlemmer, Benoit Azoulay, Élie Crit Care Commentary Seasonal influenza virus has been described as an emerging and severe pathogen in immunocompromised hosts. Since the beginning of the 2009 influenza A novel H1N1 pandemic, several series have described the clinical course of the disease in various populations. We report the clinical course of H1N1 2009 infection in 10 immunocompromised patients. Half of the patients received long-term steroid therapy. Disease was characterized by a clinical picture similar to that of non-immunocompromised patients but with prolonged course and higher mortality. BioMed Central 2010 2010-04-14 /pmc/articles/PMC2887153/ /pubmed/20392286 http://dx.doi.org/10.1186/cc8927 Text en Copyright ©2010 BioMed Central Ltd
spellingShingle Commentary
Camous, Laurent
Lemiale, Virginie
Canet, Emmanuel
Max, Adeline
Schnell, David
Le Goff, Jerome
Rabbat, Antoine
Schlemmer, Benoit
Azoulay, Élie
Clinical features of H1N1 2009 infection in critically ill immunocompromised patients
title Clinical features of H1N1 2009 infection in critically ill immunocompromised patients
title_full Clinical features of H1N1 2009 infection in critically ill immunocompromised patients
title_fullStr Clinical features of H1N1 2009 infection in critically ill immunocompromised patients
title_full_unstemmed Clinical features of H1N1 2009 infection in critically ill immunocompromised patients
title_short Clinical features of H1N1 2009 infection in critically ill immunocompromised patients
title_sort clinical features of h1n1 2009 infection in critically ill immunocompromised patients
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887153/
https://www.ncbi.nlm.nih.gov/pubmed/20392286
http://dx.doi.org/10.1186/cc8927
work_keys_str_mv AT camouslaurent clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT lemialevirginie clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT canetemmanuel clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT maxadeline clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT schnelldavid clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT legoffjerome clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT rabbatantoine clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT schlemmerbenoit clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients
AT azoulayelie clinicalfeaturesofh1n12009infectionincriticallyillimmunocompromisedpatients

Ejemplares similares